IJMS | Free Full-Text | Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation | HTML
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Protein tumor markers on plasmatic exosomes. | Download Scientific Diagram
The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer - Sasahira - 2018 - Pathology International - Wiley Online Library
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Expression of examined tumor markers in patients with melanoma... | Download Scientific Diagram
Pancreatic Cancer Tumor Markers | GeneTex
Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: New insight into the presence of the transcript variant of MUC4
Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients - ScienceDirect
Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients - ScienceDirect
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology in: Journal of the National Comprehensive Cancer Network Volume 9 Issue Suppl_5 (2011)
PDF) Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells
MIA PaCa-2 pancreatic xenograft tumor model - Hera BioLabs
Frontiers | Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition | PLOS ONE
Comparison of Two Prognostic Markers for Malignant Melanoma: MIA and S100 Я
Tumormarker beim malignen Melanom
TUMOR MARKERS - MEDizzy
Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage | Scientific Reports
MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors | Scientific Reports
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Tumor markers -
Flow cytometry analysis of morphology and stem cell marker expression... | Download Scientific Diagram
Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma | Scientific Reports
Review Expression, function and clinical relevance of MIA (Melanoma Inhibitory Activity)
